Earticle

초록

영어

Objective: This paper was aimed to investigate the current labelling trend of tar color additives in infant’s drugs used in Korea and other countries. Method: The current labelling system of the tar color additives in infant's drugs was investigated using inserted papers for drug information of infant’s drugs as well as three drug information internet sites popular in Korea including internet sites of foreign countries of USA, UK, Japan, and China for infant’s drug information. Results: Among 325 drugs registered as syrup form for infant’s drugs (sources, http://www.health.kr), 4 drugs indicated tar color related information on the internet and only 2 drugs indicated tar color additives’ name. And from the investigated results of 76 inserted papers for infant’s drug information, among 31 drugs containing tar dyes, in only 19 drugs the tar color additives’ names were notated. Among 6 drugs which do not contain tar dyes, only 1 drug was notated as ‘Dye-Free’. Conclusion: For advanced labelling system in Korea, we proposed the below guidelines. [1] The name of tar color additives used in infant’s drugs should be notated even in drug information on internet sites. [2] All drug ingredients used in infant’s drugs need to be separately notated as active and inactive species on both internet sites and inserted papers. [3] ‘Dye-Free’ notation should be mandatory for infant’s drugs which do not contain tar color additives in drug information on the internet sites as well as inserted papers.

목차

Abstract
 연구방법
 연구결과
  국내 인터넷 의약정보 사이트 조사
  의약품 포장내 제품설명서의 조사
  미국에서의 소아용 의약품 중 타르색소 사용 여부의 표기실태
 고찰 및 결론
 참고문헌

키워드

저자

• 김광준 [ Kwang Joon Kim | 조선대학교 약학대학 ]
• 방준석 [ Joon Seok Bang | 숙명여자대학교 임상약학대학원 ]
• 이원재 [ Wonjae Lee | 조선대학교 약학대학 ] Correspondence to

참고문헌

발행기관

간행물

표지보기 관심저널 등록

• 간행물명

  한국임상약학회지 [Korean Journal of Clinical Pharmacy]

• 간기

  계간

• pISSN

  1226-6051

• 수록기간

  1991~2026

• 등재여부

  KCI 등재

• 십진분류

  KDC 518 DDC 615